Global Preterm Birth and Premature Rupture of Membranes (PROM) Testing Market Growth (Status and Outlook) 2023-2029

Global Preterm Birth and Premature Rupture of Membranes (PROM) Testing Market Growth (Status and Outlook) 2023-2029

LPI (LP Information)' newest research report, the “Preterm Birth and Premature Rupture of Membranes (PROM) Testing Industry Forecast” looks at past sales and reviews total world Preterm Birth and Premature Rupture of Membranes (PROM) Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Preterm Birth and Premature Rupture of Membranes (PROM) Testing sales for 2023 through 2029. With Preterm Birth and Premature Rupture of Membranes (PROM) Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Preterm Birth and Premature Rupture of Membranes (PROM) Testing industry.

This Insight Report provides a comprehensive analysis of the global Preterm Birth and Premature Rupture of Membranes (PROM) Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Preterm Birth and Premature Rupture of Membranes (PROM) Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Preterm Birth and Premature Rupture of Membranes (PROM) Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Preterm Birth and Premature Rupture of Membranes (PROM) Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Preterm Birth and Premature Rupture of Membranes (PROM) Testing.

The global Preterm Birth and Premature Rupture of Membranes (PROM) Testing market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Preterm Birth and Premature Rupture of Membranes (PROM) Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Preterm Birth and Premature Rupture of Membranes (PROM) Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Preterm Birth and Premature Rupture of Membranes (PROM) Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Preterm Birth and Premature Rupture of Membranes (PROM) Testing players cover Abbott Laboratories, Biosynex, Cooper Surgical, Hologic, IQ Products, Medix Biochemica, Parsagen Diagnostics，Inc, Qiagen and Sera Prognostics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Preterm Birth and Premature Rupture of Membranes (PROM) Testing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
by Preterm Birth Tests
by PROM Tests

Segmentation by application
Hospitals
Diagnostic Laboratories
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
Biosynex
Cooper Surgical
Hologic
IQ Products
Medix Biochemica
Parsagen Diagnostics，Inc
Qiagen
Sera Prognostics

Please note: The report will take approximately 2 business days to prepare and deliver.